INTRODUCTION {#S1}
============

Foxp3^+^ T (Treg) cells, a distinct subset of CD4^+^ T cells, play an essential role in regulating immune tolerance and homeostasis ([@R38]). As a master transcription factor, Foxp3 plays a critical role in regulating Treg cell development and function. Foxp3-deficient mice (e.g., *Scurfy* mice) exhibit hyperactivated effector T cells and dramatically enhanced pro-inflammatory cytokine production and are characterized by early lethality at around 16--25 days after birth due to lymphadenopathy, splenomegaly, and inflammation within multiple organs ([@R4]; [@R24]). A similar phenotype has also been observed in humans with a loss of function in FOXP3. These patients develop IPEX syndrome (immunodysregulation, polyendocrinopathy, and enteropathy, X-linked syndrome) with multi-organ inflammation and autoimmunity, and a considerable reduction in the lifespan of the individual ([@R8]; [@R26]).

Two distinct Treg cell populations express Foxp3, thymus-derived Treg (tTreg) cells, and peripherally induced Treg (pTreg) cells ([@R14]; [@R22]; [@R28]; [@R45]). For both tTreg and pTreg cells, Foxp3 is known to be induced through T cell receptor (TCR) stimulation together with various cytokine signals, including interleukin-2 (IL-2) and transforming growth factor β (TGF-β) ([@R13]; [@R18]; [@R19]; [@R51]). TCR and CD28 stimulation activates the NF-κB signaling pathway ([@R37]; [@R43]), while IL-2 and TGF-β signals initiate the activation of STAT5 and SMADs ([@R51]), respectfully. All these transcription factors are able to bind to the Foxp3 locus and coordinately regulate the expression of Foxp3 and development of Treg cells ([@R52]). In contrast, IL-23, a cytokine that promotes development of pathogenic Th17 cells, has been shown to suppress development of Tregs ([@R21]), but the mechanism by which IL-23 mediates this effect on Tregs has not been studied.

Full commitment of the Treg cell lineage also requires integration of additional signaling pathways with the Foxp3 program, including some of the members of AGC family of kinases that are induced downstream of the TCR. It has been reported that phosphoinositide-3-kinase (PI3K) and Akt pathways play an essential role in regulating Treg cell differentiation ([@R40]).

Our regulatory network analysis of Th17 cells predicted that Serum- and glucocorticoid-induced kinase 1 (SGK1), a member of the AGC family of kinases that is downstream of IL-23R, may also play a critical role in regulating the balance between Foxp3^+^ Tregs and pro-inflammatory Th17 cells. Its expression is modulated by glucocorticoids and serum ([@R27]; [@R32]), and it plays an important part in activating the epithelial sodium channel, ENaC ([@R5]), in the aldosterone-sensitive distal nephron (ASDN) ([@R44]). So far, the role of SGK1 in different processes, such as the regulation of ion transport, enzymatic activities, transcriptional regulation, release of hormones, cell volume, and cell proliferation, and apoptosis, has been extensively studied ([@R11]; [@R30]; [@R29]). However, to date, there are limited studies exploring the role of SGK1 in the immune system, particularly during T cell differentiation. Our previous work first demonstrated that SGK1 plays a critical role in the differentiation of Th17 cells by regulating IL-23R expression ([@R46]). Loss of SGK1 reduces the expression of IL-23R and limits development of pathogenic Th17 cells. A recent study also indicates that activation of SGK1 by mTORC2 can regulate the development of Th1 and Th2 cells ([@R15]).

In the present study, we show that SGK1 functions as a negative regulator for Treg cell development. Loss of SGK1 in Treg cells results in increased Treg-suppressive function. Mice deficient in SGK1 specifically in Treg cells exhibit improved immune homeostasis and are protected from the development of multiple autoimmune diseases. Moreover, the activity of SGK1 in CD4^+^ T cells that is required for promoting a pathogenic Th17 cell response is also required for disarming the protective Treg cell response in an IL-23-dependent manner. Deficiency of SGK1 specifically in Treg cells leads to an increased frequency of Treg cells with improved function *in vivo* in the context of gut inflammation. Mechanistically, the loss of SGK1 limits phosphorylation of Foxo1, resulting in nuclear retention of Foxo1, which directly promotes the transactivation and maintenance of Foxp3. Therefore, we demonstrate that SGK1 functions as a pivotal node in regulating the balance of pro- and anti-inflammatory T cells development during autoimmunity.

RESULTS {#S2}
=======

SGK1 Signaling Is Active in Treg Cells {#S3}
--------------------------------------

We have previously shown that *Sgk1* mRNA is highly expressed under Th17 differentiation conditions and that exposure of naive T cells to TGF-β can also induce substantial transcription of *Sgk1* ([@R46]). We confirmed here that in addition to Th17 cells, *Sgk1* mRNA is expressed in both pTreg and tTreg cells with tTregs expressing the highest level, as compared with Th17 cells ([Figure 1A](#F1){ref-type="fig"}). However, after IL-2 stimulation either *in vitro* or *in vivo*, which promotes Treg cell expansion and presumably function, *Sgk1* expression was reduced in tTreg cells ([Figures S1A and S1B](#SD1){ref-type="supplementary-material"}), suggesting IL-2 exerts as a negative signal for Sgk1 expression. To investigate the function of SGK1 in tTreg cells, we first compared SGK1 activity between tTreg and naive T cells at steady state. We observed that tTreg cells exhibited enhanced phosphorylation of p27, one downstream target of SGK1 ([@R17]). Moreover, we found tTreg cells also contain higher levels of p27, phospho-p27, Foxo1, and raptor compared with naive T cells, whose expression all depend on SGK1 activity ([@R2]; [@R3]) ([Figures 1B](#F1){ref-type="fig"} and [1C](#F1){ref-type="fig"}). It is known that TCR signaling is crucial for Treg cell function ([@R40]). Using anti-CD3/CD28 stimulation, we observed increased phosphorylation of p27 and Foxo1 in tTreg cells ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}), suggesting that SGK1 activity is likely promoted by TCR signaling in tTreg cells and regulates tTreg function. To examine the role of SGK1 in Treg cells, we generated mice with an SGK1 deficiency specifically in Treg cells (*Foxp3^Cre^Sgk1^fl/fl^*). Under steady state, the *Foxp3^Cre^Sgk1^fl/fl^* mice had similar frequencies of Foxp3^+^ Treg cells from spleen, draining lymph nodes (dLN), and lamina propria (LP), as compared to wild-type (WT) mice ([Figures 1F](#F1){ref-type="fig"} and [1G](#F1){ref-type="fig"}). Interestingly, upon TCR stimulation, tTreg cells from the *Foxp3^Cre^Sgk1^fl/fl^* mice displayed a higher proliferative rate as indicated by their expression of Ki-67, a cellular marker for proliferation ([Figure 1H](#F1){ref-type="fig"}).

SGK1 Limits tTreg Cell Function {#S4}
-------------------------------

It has been reported that Treg cells are crucial for immune self-tolerance and controlling inflammation ([@R12]; [@R45]; [@R47]). We next assessed the function of the tTreg cells from *Foxp3^Cre^Sgk1^fl/fl^* mice by *in vitro* suppression assay. CD4^+^Foxp3^+^ Treg cells were isolated from spleen and LNs by using Cre-YFP as a sorting marker, and co-cultured with naive WT T cells. Compared with WT tTreg cells, *Foxp3^Cre^Sgk1^fl/fl^* tTreg cells showed an enhanced ability to inhibit the TCR-stimulated proliferation of WT naive CD4^+^ T cells ([Figure 2A](#F2){ref-type="fig"}). The signature markers and co-stimulatory molecules, such as CTLA-4, Lag-3, GITR, CD25, and ICOS, on activated tTreg cells from *Foxp3^Cre^Sgk1^fl/fl^* mice were increased, compared with those from WT mice ([Figure 2B](#F2){ref-type="fig"}).

We next examined tTreg cell function *in vivo* in *Foxp3^Cre^ Sgk1^fl/fl^* mice by induction of experimental autoimmune encephalomyelitis (EAE), a murine model of human disease multiple sclerosis. After immunization with myelin oligodendrocyte glycoprotein (MOG) peptide, *Foxp3^Cre^Sgk1^fl/fl^* mice developed much less severe EAE than control mice ([Figure 2C](#F2){ref-type="fig"}). Analysis of the infiltrating T cells within the CNS showed that *Foxp3^Cre^Sgk1^fl/fl^* mice had fewer Th1 and Th17 cells, but more Treg cells ([Figures 2D](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). Consistent with the *in vitro* assay ([Figure 1F](#F1){ref-type="fig"}), *in vivo* bromodeoxyuridine (BrdU) incorporation showed that Treg cells from *Foxp3^Cre^Sgk1^fl/fl^* mice with EAE exhibited higher proliferative rates for Foxp3^+^ Treg cells than WT mice ([Figure 2F](#F2){ref-type="fig"}). Given that tTreg cells are the main regulators during active EAE development ([@R25]), these results demonstrate a critical role for SGK1 in restraining tTreg cell expansion and function, both *in vitro* and *in vivo*.

SGK1 Represses Treg Cell Homeostasis {#S5}
------------------------------------

We then asked whether SGK1 deletion in Treg cells altered Treg function in systemic immune tolerance and homeostasis. While the *Foxp3^Cre^Sgk1^fl/fl^* mice at 6--8 weeks old exhibited normal T cell composition in the peripheral lymph nodes (LNs) and spleens (data not shown), the mice at 24 weeks old showed reduced proportions of activated CD4^+^ (CD62L^lo^CD44^+^) T cells ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). Their CD4^+^CD44^hi^ memory T cells showed decreased interferon (IFN)-γ expression ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}), suggesting that a reduction in activated/memory cells may be because of increase in Treg activity in *Foxp3^Cre^Sgk1^fl/fl^* mice. To further test the ability of Treg cells in the absence of SGK1 to control spontaneous inflammation and regulate immune tolerance *in vivo*, we performed a Treg rescue assay in Foxp3-deficient *Scurfy* mice, which develop a spontaneous Th1 inflammatory response associated with severe multiorgan tissue inflammation ([@R6]). Transfer of purified tTreg cells into neonatal *Scurfy* mice rescues these pathological phenotypes ([@R23]). Although both WT and SGK1-deficient tTreg cell transfer prevented development of tissue inflammation in *Scurfy* mice, the frequency of CD4^+^Foxp3^+^ cells in the SGK1-deficient tTreg cells recipients was higher than that of WT Treg cells ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). Additionally, as compared to WT tTreg cells, the CD4^+^CD44^hi^ effector T cells from the recipient *Scurfy* mice that received SGK1-deficient tTreg cells displayed a reduced Th1 response ([Figures 3G](#F3){ref-type="fig"} and [3H](#F3){ref-type="fig"}), consistent with the better repressive ability of SGK1-deficient tTreg cells *in vitro* ([Figure 2A](#F2){ref-type="fig"}). These data illustrate that loss of SGK1 in tTreg cells facilitates tTreg cell function and SGK-deficient Tregs are therefore are better able to control autoimmune and inflammatory responses *in vivo*.

SGK1 Represses *Foxp3* Expression via Regulating IL-23R {#S6}
-------------------------------------------------------

Our network analysis predicted that SGK1 is downstream of IL-23R signaling, where it has been reported to regulate Treg cells ([@R21]). Activation of SGK1 is also implicated in repression of the Treg lineage in response to high salt exposure ([@R16]). To understand the relationship between IL-23R signaling and development of Foxp3^+^ Tregs *in vivo*, we transferred CD4^+^CD25^−^CD45RB^hi^ T cells from IL-23R-GFP reporter mice into *Rag2*^−^*^/^*^−^ recipients to induce colitis. Six weeks after transfer, CD4^+^GFP^+^ and CD4^+^GFP^−^ T cells from different organs were sorted and gene expression analysis by real-time PCR was performed. IL-23R-expressing (IL-23R-GFP^+^) T cells expressed high levels of *Sgk1* when multiple organs were interrogated, suggesting that IL-23R signaling may promote SGK1 expression in T cells during tissue inflammation ([Figure 4A](#F4){ref-type="fig"}). Given that γδ T cells were reported to express IL-23R ([@R36]), we also found upregulated *Sgk1* expression in γδ T cells after IL-23 treatment ([Figure S2](#SD1){ref-type="supplementary-material"}).

To further study the relationship between SGK1 and IL-23R signaling, we determined the effects of overexpressing SGK1 and IL-23R in activated naive CD4^+^ T cells in the presence of various cytokines. Overexpression of IL-23R significantly enhanced SGK1 expression ([Figure 4B](#F4){ref-type="fig"}) and kinase activity ([Figure S3](#SD1){ref-type="supplementary-material"}) specifically in the presence of IL-23, suggesting that IL-23 signaling can induce the expression of SGK1 during Th17 cell differentiation. It has been reported that IL-23R cannot be induced prior to the initiation of the Th17 program ([@R42]). Interestingly, forced expression of SGK1 increased the expression of IL-23R in T cells ([Figure 4C](#F4){ref-type="fig"}). IL-23R expression is suppressed in the presence of TGF-β. However, forced over-expression of SGK1 overcame this inhibition and enhanced *Il23r* even under TGF-β conditions ([Figure 4C](#F4){ref-type="fig"}). Thus, IL-23R and SGK1 function as a positive feedforward loop to enhance each other's expression. We also analyzed *Foxp3* expression under these same conditions to study the effect of SGK1 and IL-23 stimulation on *Foxp3* expression. We observed that SGK1 over-expression inhibited expression of *Foxp3*, even when *Foxp3* expression was further enhanced by activation with TGF-β or IL-23 ([Figure 4D](#F4){ref-type="fig"}). Given that Th17 and pTreg cells can be reciprocally regulated ([@R1]; [@R48]), we examined the expression of Foxp3 following IL-23 stimulation of WT and *Cd4^Cre^Sgk1^fl/fl^* T cells *in vitro*. We found that not only was the production of IL-17 compromised, but also Foxp3 expression was enhanced simultaneously in the SGK1-deficient T cells ([Figure 4E](#F4){ref-type="fig"}). These data therefore suggest that the activation of SGK1 during Th17 cell differentiation initiates a feedback inhibitory loop to suppress induction of Foxp3 and promote IL-23R expression in an IL-23-dependent manner.

IL-23 Restrains Treg Cell Development *In Vivo* Partly via SGK1 {#S7}
---------------------------------------------------------------

IL-23 signaling has been shown to affect the development of intestinal Treg cells ([@R21]). We tested the role of the IL-23R-SGK1 axis during *in vivo* pTreg generation. We transferred CD45.2^+^CD4^+^CD45RB^hi^CD25^−^ cells into *Rag2*^−^*^/^*^−^ mice from WT, *Il23r*^−^*^/^*^−^, *Sgk1*^−^*^/^*^−^ or *Il23r*^−^*^/^*^−^*Sgk1*^−^*^/^*^−^ donor mice, together with CD45.1^+^CD4^+^CD45RB^hi^CD25^−^ cells as an internal control at a ratio of 1:1. Ten weeks after transfer, we isolated the T cells from the gut and analyzed their cytokine profile ([Figure 4F](#F4){ref-type="fig"}). As expected, CD45.1^+^ and CD45.2^+^ WT donor cells exhibited identical IL-17 and IFN-γ production in this transfer model ([Figure 4G](#F4){ref-type="fig"}). Moreover, consistent with previous data ([@R20]), we observed a reduction in both IFN-g and IL-17-producing T cells in the LP from *Il23r*^−^*^/^*^−^ donor mice ([Figure 4G](#F4){ref-type="fig"}). Similar to *Il23r*^−^*^/^*^−^ T cells, reduced Th1 and Th17 responses were also found in either *Sgk1*^−^*^/^*^−^ or *Il23r*^−^*^/^*^−^*Sgk1*^−^*^/^*^−^ T cells ([Figures 4G](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}). In contrast, we found an increased frequency of Foxp3^+^ T cells from the *Sgk1*^−^*^/^*^−^ T cells compared with WT T cells. Interestingly, *Il23r*^−^*^/^*^−^ cells donor cells showed an even greater increase in Foxp3 expression compared to the *Sgk1*^−^*^/^*^−^ transferred T cells, suggesting that SGK1 may only partially account for restraint of Foxp3 expression in Treg cells. However, the increase in Foxp3 expression was similar in both *Il23r*^−^*^/^*^−^*Sgk1*^−^*^/^*^−^ and *Il23r*^−^*^/^*^−^ T cells compared to *Sgk1*^−^*^/^*^−^ T cells ([Figures 4H](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}). These results reveal that both IL-23R and its downstream kinase SGK1 are able to repress expression of Foxp3 within pTregs.

SGK1 Regulates Reciprocal Development of Th17 and pTreg Cells during Intestinal Inflammation {#S8}
--------------------------------------------------------------------------------------------

We then asked whether such SGK1 could regulate development of Th17 cells and Tregs *in vivo*, without using very strong immunization regimens that would bias T cell fates. We transferred WT or SGK1-deficient CD4^+^CD25^−^CD45RBhi T cells into Rag2^−/−^ recipients and observed the mice for the development of intestinal inflammation as measured by weight loss and histopathology. We observed that WT T cells when transferred to the Rag2^−/−^ mice induced weight loss and clinical histopathological signs of colitis whereas T cells from the Sgk1^−/−^ mice were not able to transfer colitis and appear to be protected from development of colitis ([Figures 5A](#F5){ref-type="fig"} and [5B](#F5){ref-type="fig"}). SGK1-deficient CD4^+^ T cells isolated from Rag2^−/−^ recipients exhibited reduced expression of IL-23R and production of pro-inflammatory cytokines IFN-γ and IL-17. The transferred T cells from the Sgk1^−/−^ mice showed an increase in the frequency of Foxp3^+^ T cells in the gut compared with WT T cells ([Figures 5C](#F5){ref-type="fig"}--[5F](#F5){ref-type="fig"}). These data suggest that SGK1 is also involved in the regulation of reciprocal differentiation of Th17 and FoxP3^+^Treg cells *in vivo*.

Cell-Intrinsic Role of SGK1 in Regulating pTreg Differentiation and Function {#S9}
----------------------------------------------------------------------------

In order to examine whether SGK1 plays an intrinsic role within pTreg cells for Foxp3 expression, we differentiated naive T cells from *Foxp3^Cre^Sgk1^fl/fl^* in presence of TGF-β to induce expression of Foxp3 *in vitro*. Under these *in vitro* differentiation conditions, *Foxp3^Cre^Sgk1^fl/fl^* T cells displayed increased Foxp3 compared with WT T cells ([Figure 6A](#F6){ref-type="fig"}). Similar to tTreg cells, SGK1-deficient Foxp3^+^ pTreg cells exhibited an increased suppressive capacity in inhibiting the proliferation of WT T effector cells ([Figure 6B](#F6){ref-type="fig"}). We next examined the functional ability of pTregs differentiated *in vitro* from SGK1-deficient T cells to induce colitis upon adoptive transfer model. We transferred CD4^+^CD45RB^hi^YFP^−^ cells from WT and *Foxp3^Cre^Sgk1^fl/fl^* mice into *Rag2*^−^*^/^*^−^ mice to induce colitis. We observed that, whereas WT T cells could induce both clinical and histopathological disease, *Foxp3^Cre^Sgk1^fl/fl^* T cells protected mice from development of intestinal inflammation in T cell-induced colitis ([Figures 6C](#F6){ref-type="fig"} and [6D](#F6){ref-type="fig"}). We observed reduced Th1 and Th17 development in the gut in the mice that received *Foxp3^Cre^ Sgk1^fl/fl^* T cells 10 weeks after transfer, concomitant with an increase in the frequency of pTreg cells ([Figures 6E](#F6){ref-type="fig"} and [6F](#F6){ref-type="fig"}). Thus, deficiency in SGK1 resulted in both *in vitro* and *in vivo* elevated pTreg cells and protected mice from intestinal inflammation.

SGK1 Restrains Foxp3 Expression via Reduced Foxo1 Nuclear Exclusion {#S10}
-------------------------------------------------------------------

To gain more molecular insight into how SGK1 regulates Treg cell development and function, we used activated Foxp3^+^ tTreg cells from spleens of WT and *Foxp3^Cre^Sgk1^fl/fl^* mice and performed a multiplex expression profiling experiment using nanostring nCounter analysis. Nanostring multiplex expression analysis of WT and *Foxp3^Cre^Sgk1^fl/fl^* Foxp3^+^ tTreg cells revealed an increase in the expression of Treg related genes and decreased expression of Th17 genes in SKG1-deficient Treg cells ([Figure 7A](#F7){ref-type="fig"}). Expression of selected genes was further confirmed by RT-PCR, including *Foxo1* and *Il23r*, showing a decreased *Il23r* expression and an increased *Foxo1* expression in *Foxp3^Cre^Sgk1^fl/fl^* tTreg ([Figure 7B](#F7){ref-type="fig"}). SGK1 has been shown to directly phosphorylate Foxo1, resulting in nuclear exclusion of Foxo1 ([@R35]). Other studies have shown that Foxo1 not only has a role in affecting the genomic landscape for Treg cell development but also directly transactivates Foxp3 expression ([@R31]; [@R35]). We isolated Foxp3^+^ Treg cells from either WT or *Foxp3^Cre^Sgk1^fl/fl^* mice and then activated them with anti-CD3 and anti-CD28. Immunostaining showed attenuated Foxo1 nuclear clearance and increased accumulation of Foxo1 in the nucleus of SGK1-deficient compared with WT Treg cells upon activation ([Figures 7C](#F7){ref-type="fig"} and [7D](#F7){ref-type="fig"}), consistent with the increase in Foxp3 activity of the SGK1-deficient Treg cells. It has been reported that Foxo1 could directly bind to the Foxp3 CNS1 region and promote Foxp3 expression ([@R34]). To determine how SGK1 regulates Foxp3 expression, we transfected WT or *Foxp3^Cre^Sgk1^fl/fl^* naive T cells with Foxp3 luciferase reporter constructs with the CNS1 region and tested luciferase activity under Th0 or pTreg conditions. We observed enhanced Foxp3 transcriptional activity in *Foxp3^Cre^Sgk1^fl/fl^* as compared to WT T cells. To further determine the specificity of binding and transactivation, we observed that the transactivation of Foxp3 was inhibited when the Foxo-binding site in CNS1 was mutated ([Figure 7E](#F7){ref-type="fig"}). In addition, given that Foxo1 phosphorylation by SGK1 directly affects Foxp3 transactivation, we next tested how activation status of SGK1 affects Foxp3 expression. When retroviral constructs of WT, the constitutively active (^S422D^SGK1) or inactive (^K127N^SGK1) form of SGK1 were transfected into WT naive T cells that were then activated in the presence of TGF-β, we observed that Foxp3 expression was inhibited when WT SGK1 was overexpressed and further inhibited by expression of constitutively active SGK-1 (^S422D^SGK1) ([Figure 7F](#F7){ref-type="fig"}). We also confirmed that the control group and ^K127N^SGK1-infected group exhibited more nuclear expression of Foxo1 than WT SGK1 or ^S422D^SGK1-infected groups ([Figure 7G](#F7){ref-type="fig"}), suggesting the kinase activity of SGK1 determines Foxo1 location. Foxo1 acts as a transcription factor in a positive feedback manner ([@R10]; [@R46]); therefore, nuclear Foxo1 can enforce its own transactivation and expression. We examined the different SGK1-mutant-infected groups and found higher SGK1 kinase activity correlated with lower Foxo1 expression ([Figure 7H](#F7){ref-type="fig"}). These findings support the idea that as phosphorylation target of Sgk-1, Foxo1, which regulates Foxp3 expression is limited by both expression and activation of SGK1. Therefore, SGK1 restrains regulatory T cell function by controlling Foxo1 activity.

DISCUSSION {#S11}
==========

We previously developed a high-density temporal transcriptional network for differentiation of Th17 cells and connected this transcriptional network to known protein interactions associated with IL-23R signaling ([@R46]; [@R50]). This network analysis identified SGK1, a member of the AGC family of serine/threonine protein kinases, as a pivotal node that regulates the differentiation of pathogenic Th17 cells and the resulting balance between Th17 cells and Foxp3^+^ Tregs. In this paper, we validated this network analysis, by showing that loss of SGK1 not only inhibits the development of Th17 cells but also found that it induces stable Tregs such that deletion of SGK1 in Tregs makes mice highly resistant to the development of autoimmunity.

Loss of SGK1 within Treg cells makes them highly potent and stable, promoting their ability to suppress pro-inflammatory responses and maintain tissue homeostasis and tolerance. Phosphorylation of Foxo1 by SGK1 deactivates the protein by exporting it out of the nucleus, thereby preventing it from binding to the *Foxp3* locus, and limiting its ability to prepare the genomic landscape for expression of *Foxp3* gene ([@R3]; [@R9]). This is consistent with our data showing an enhancement of Treg cell generation and function by conditional deletion of SGK1 within Tregs. As a critical transcription factor controlling Foxp3 expression, loss of Foxo1 has been shown to disrupt Treg function, resulting in hyperactivation of Th1-like immune responses ([@R35]). Consistent with this observation, our studies demonstrate that conditional deletion of SGK1 in Treg cells stabilizes Foxo1 in the nucleus and promotes Treg-suppressive function. It has previously been reported that Foxo1 serves as a ''placeholder'' for Foxp3 during Treg cell development ([@R39]). Thus, nuclear exclusion of Foxo1 by SGK1 could not only inhibit Foxp3 expression, but also alter the genomic landscape during Treg cell development. Our expression profiling showed that besides enhanced *Foxo1* expression, there was a decrease in Th1- and Th17-associated genes in SGK1-deficient Treg cells, including *Ifng*, *Rorc*, *Rora*, and *Il23r*. We also found that SGK1-deficient Treg cells suppressed Th1 and Th17 responses more efficiently at both steady and inflammatory states. Consistent with this observation, Foxo1-deficient Treg cells display the opposite phenotype of SGK1-deficient Treg cells, producing large amounts of IFN-γ and IL-17 at a quiescent state ([@R34]). These data implicate the SGK1-Foxo1 axis in specification of Treg cell identity and stability. Activation of Foxo1 results in destabilization of Treg cell function and development. Therefore, SGK1 is a pivotal kinase that regulates the balance between Tregs and Th17 cells through activation of Foxo1, which reciprocally drives the expression of Foxp3 and IL-23R.

IL-23R signaling has been previously shown to suppress development and accumulation of Foxp3^+^ Treg cells by a direct cell-intrinsic mechanism during intestinal inflammation ([@R21]). It has also been reported that, as opposed to *in*-*vitro*-derived pTreg cells, intestinal Foxp3^+^ Treg cells also co-express RORγt, which potentially induces expression of IL-23R ([@R41]; [@R49]). This intermediate phase of T cell development can be observed in the gut environment. The fact that IL-23 regulates Treg cells in the gut indicates that IL-23 potentially functions synergistically with environmental cues to regulate the development of Tregs and Th17 cells. As one of the downstream targets of IL-23R, we showed that SGK1 expression correlates with IL-23R induction during intestinal inflammation. It is known that SGK1 plays a critical role on the epithelia cells for Na^+^ transport and could lead to an imbalance of sodium homeostasis in the intestinal tract. We and others also found that Na^+^ concentration is not only critical for T cell differentiation and function ([@R16]; [@R46]) but also affects gut commensalism. The loss of SGK1 in Tregs could therefore affect immune regulation via both intrinsic molecular signaling mechanisms by regulating by impacting Treg stability and function but also by cell-extrinsic mechanisms such as by affecting microbiota. Therefore, regulation of pTreg development by SGK1 following IL-23 signaling must be context dependent. Our gain-of-function experiments demonstrate that IL-23R and SGK1 form a positive feedforward loop, indicating that IL-23 represses Foxp3 expression in a SGK1-dependent manner. Consistent with previous observations ([@R21]), our studies thus provide a mechanism by which IL-23R signaling regulates Treg function in the gut.

Although superficially, the phenotype of *Il23r*^−^*^/^*^−^ mice looks very similar to *Sgk1*^−^*^/^*^−^ mice in terms of elevated Treg function, and, upon closer observation, the phenotype of *Il23r*^−^*^/^*^−^ or *Il23r*^−^*^/^*^−^*Sgk1*^−^*^/^*^−^ mice appears to be enhanced as compared with *Sgk1*^−^*^/^*^−^ mice, suggesting that IL-23R signaling must employ additional mechanisms to suppress Treg function in addition to SGK1. STAT3, which is downstream of IL-23R signaling has been shown to be a negative regulator of Foxp3 expression ([@R1]; [@R33]). Therefore, SGK1 and STAT3 downstream of IL-23R could work together to induce stronger inhibition of Treg development and function.

A balance between effector and Treg cells is crucial for maintaining immune homeostasis and tolerance during various physiological or pathological processes. SGK1 appears to be a pivotal kinase that regulates the balance between Th17 and Treg cells by activation of the transcription factor Foxo1. Although the role of SGK1 in Th17 development has been studied extensively, this current study highlights a cell-intrinsic role for SGK1 in Treg development and function. Based on our studies, blocking SGK1 activation using a small-molecular-weight inhibitor could be a potential strategy to ameliorate Th17-mediated inflammation and enhance development of Treg cells, shifting the balance away from a pro-inflammatory Th17 response to a more tissue protective Treg response.

EXPERIMENTAL PROCEDURES {#S12}
=======================

Animals {#S13}
-------

C57BL/6 (B6), *Rag2*^−^*^/^*^−^, *Foxp3^Cre^*, and *Scurfy* mice were purchased from Jackson Laboratory; *Cd4^Cre^* mice were purchased from Taconic; *Il23r^gfp^*, *Il23r*^−^*^/^*^−^, and *Sgk1^fl/fl^* mice were described previously ([@R7]; [@R11]; [@R36]). All experiments were carried out in accordance with guidelines prescribed by the Institutional Animal Care and Use Committee (IACUC) at Harvard Medical School.

Antibodies {#S14}
----------

The following antibodies were used in fluorescence-activated cell sorting (FACS) and cell sorting: CD45.1 (A20, BioLegend), CD45.2 (104, BioLegend), CD4 (H129.19, BD Pharmingen), CD25 (7D4, BD Pharmingen), IL-17A (TC11-18H10.1, BD Pharmingen), IFN-g (XMG1.2, BD Pharmingen), CD44 (IM7, Bio-Legend), CD62L (MEL-14, BioLegend), CD25 (7D4, BD Pharmingen), Lag3 (46-2231-80, eBioscience), Nrp1 (FAB566A, R&D Systems), Ki67 (SolA15, eBioscience), CTLA4 (14D3, eBioscience), GITR (DTA-1, eBioscience), ICOS (C398.4A, BioLegend), Foxp3 (FJK-16 s, eBioscience), p27 (sc-776, Santa Cruz Biotechnology), p-p27 (ab85047, Abcam), Foxo1 (ab39670, Abcam), p-Foxo1 (9461S, Cell Signaling Technology), Raptor (ab5454, Abcam), Brdu (B44, BD Pharmingen).

*In Vitro* T Cell Differentiation {#S15}
---------------------------------

Naive (CD44^lo^CD62L^+^CD25^−^) or memory (CD44^hi^CD62L^lo^CD25^−^) CD4^+^ T cells was obtained from spleens and LNs of indicated mice by flow cytometry accordingly. The purity of isolated T cell populations routinely exceeded 98%. Naive T cells were stimulated with plate-bound anti-CD3 (145-2C11, 1 μg/mL) and anti-CD28 (PV-1, 1 μg/mL) and polarizing cytokines (R&D Systems).

Flow Cytometry {#S16}
--------------

For intracellular cytokine staining, cells were cultured as described above and stimulated for 4 hr at 37° C in culture medium containing phorbol 12-myristate 13-acetate (PMA) (50 ng/mL; Sigma), ionomycin (1 μg/mL; Sigma), and monensin (GolgiStop; 1 μg/mL; BD Bioscience). Surface markers were stained in PBS with 1% FCS for 20 min at room temperature and then subsequently fixed in Cytoperm/Cytofix (BD Bioscience), permeabilized with Perm/Wash Buffer (BD Bioscience), and stained with cytokine antibodies diluted in Perm/Wash. For Foxp3 stating, cells were fixed and permeabilized with the Foxp3 Staining Buffer Set, according to the manufacturer's instructions (eBioscience). All flow cytometry data were acquired on a FACS Calibur (Becton Dickinson) and analyzed with FlowJo software (Tree Star).

Suppression Assay {#S17}
-----------------

Naive CD4^+^ T effectors (5 × 10^5^) were cultured with iTregs (5 × 10^5^, titrated down as described) in 96-well round-bottom plates (Corning). Cells were stimulated with anti-CD3/28 and left in culture for 5 days. Cells were pulsed with 1 μCi 3H thymidine for the last 16 hr of incubation. Mean thymidine incorporation in triplicate wells was measured using a β counter (LS 5000; Beckman Coulter).

qRT-PCR {#S18}
-------

For gene expression detection, total RNA was isolated from whole cells using the QIAGEN miniRNA extraction kit following the manufacturer's instructions. RNA was quantified and complementary DNA was reverse-transcribed using the cDNA archival kit (Applied Biosystems) following the manufacturer's instructions. The cDNA samples were used at 20 ng/well in a 384-well plate and run in triplicate. PCRs were set up using TaqMan Universal PCR Master Mix (Applied Biosystems) on an ABI Prism 7500 Sequence Detection System. Quantification of relative mRNA expression was normalized to the expression of GAPDH. Primer-probe mixtures were purchased from Applied Biosystems: *Foxp3* (Mm00475162); *Foxo1 (Mm00490672-m1)*; *Il23r (Mm00519943-m1)*; *Rorc (Mm01261022-m1)*; *Il2r (Mm01340213_m1)*; *Sgk1 (Mm00441380-m1)*; *Ifng (Mm01168134_m1)*; *GAPDH (4352339E).*

Plasmids {#S19}
--------

Murine SGK1 or IL-23R (IMAGE cDNA clone) was cloned into the MSCV-IRES-GFP and MSCV-IRES-Thy1.1 vectors at EcoRI/XhoI and BglII/XhoI sites, respectively.

Retroviral Transduction {#S20}
-----------------------

Retroviral particles were produced by transiently transfecting HEK293T cells with retroviral packaging constructs (PCL, Gag/pol) and expression plasmids MSCV-IRES-GFP or MSCV-IRES-Thy1.1 using Fugene HD (Roche). 72 hr after transfection, viral culture supernatants were harvested, supplemented with polybrene (8 mg/mL) and added to previously stimulated T cells (5 × 10^5^/well, plate-bound anti-CD3/CD28 and different combination of cytokines for 24 hr). Cultures were centrifuged at 800 × *g* for 45 min at 25° C.

Reporter Assays {#S21}
---------------

HEK293T cells (1 × 10^5^ cells/well, 48-well plate) were transiently transfected with the indicated expression vectors, empty vector controls as well as the promoter firefly luciferase-reporter constructs and Renilla luciferase reporter vector (Promega) with Fugene HD (Promega). 48 hr after transfection, luciferase expression was determined by measuring luminescence with the Dual-Luciferase Reporter Assay System (Promega). The firefly luciferase activity was normalized to Renilla luciferase activity. Data are representative of at least two independent experiments; each data point represents duplicate values.

Immunofluorescence Microscopy {#S22}
-----------------------------

Treg cells were isolated from WT and SGK1-deficient were stimulated with plate-bound anti-CD3 (1 μg/mL) and anti-CD28 (1 μg/mL) on chamber slides at 37° C for 20 min. After fixation with 4% paraformaldehyde, cells were permeabilized with Foxp3 Fixation/Permeabilization buffer (eBioscience) according to the manufacturer's instructions. After blocking with Permeabilization buffer and 3% BSA, cells were incubated with 1:250 diluted mouse anti-Foxo1 (ab1102, Abcam), rat anti-Foxp3 (FJK-16 s, eBioscience), and rabbit anti-SGK1 (ab43606, Abcam), followed by Alexa555-anti-mouse, allophyco-cyanin (APC)-anti-rabbit and fluorescein isothiocyanate (FITC)-anti-rat secondary antibodies in Permeabilization buffer and 1% BSA. Slides were mounted with gold anti-fading mounting buffer (Invitrogen). Images were acquired with a Leica TCS SP5-II confocal microscope. For quantitative analysis, five fields were selected randomly and total cells in the field were manually counted and grouped with Volocity software (PerkinElmer), on the basis of their Foxo1 nuclear or cytosolic localization.

T Cell-Induced Colitis {#S23}
----------------------

CD4^+^ T cells were purified from the spleen and LNs of WT and SGK1-deficient mice by positive selection with magnetic beads (Miltenyi Biotec), and naive CD4^+^CD25^−^ CD45RB^hi^ T cells were purified by sorting with flow cytometry. 7 × 10^5^ naive T cells were injected intraperitoneally (i.p.) into age- and sex-matched *Rag2* ^−/−^ mice and weight loss was monitored.

Assessment of Intestinal Inflammation {#S24}
-------------------------------------

Tissues were graded semiquantitatively from 0 to 5 in a blinded fashion: score 0, no changes observed; score 1, minimal scattered mucosal inflammatory cell infiltrates, with or without minimal epithelial hyperplasia; score 2, mild scattered to diffuse inflammatory cell infiltrates, sometimes extending into the sub-mucosa and associated with erosions, with minimal to mild epithelial hyperplasia and minimal to mild mucin depletion from goblet cells; score 3, mild to moderate inflammatory cell infiltrates that were sometimes transmural, often associated with ulceration, with moderate epithelial hyperplasia and mucin depletion; score 4, marked inflammatory cell infiltrates that were often transmural and associated with ulceration, with marked epithelial hyperplasia and mucin depletion; score 5, marked transmural inflammation with severe ulceration and loss of intestinal glands.

EAE Induction {#S25}
-------------

Mice were immunized subcutaneously (s.c.) in the flanks with an emulsion containing MOG35--55 (100 μg/mouse) and *M. tuberculosis* H37Ra extract (3 mg/mL, Difco Laboratories) in CFA (100 μL/mouse). Pertussis toxin (100 μg/mouse, List Biological Laboratories) was administered i.p. on days 0 and 2. Mice were monitored and assigned grades for clinical signs of EAE using the following scoring system: 0, healthy; 1, limp tail; 2, impaired righting reflex or waddled gait; 3, hind limb paralysis; 4, total limb paralysis; 5, moribund or death.

Adoptive Transfers {#S26}
------------------

CD45.2^+^CD4^+^CD45RB^hi^CD25^−^ cells from WT, *Il23r*^−^*^/^*^−^, *Sgk1*^−^*^/^*^−^, or *Il23r*^−^*^/^*^−^ *Sgk1*^−^*^/^*^−^ donor mice, together with CD45.1^+^CD4^+^CD45RB^hi^CD25^−^ cells as internal control at a ratio of 1:1, were injected intravenously into *Rag2*^−^*^/^*^−^ mice. 10 weeks after transfer, mice were sacrificed for analysis. For neonatal transfer, GFP^+^ Treg cells were isolated from WT or SGK1-deficient mice and were resuspended in 1 × 10^6^ cells/25 mL PBS. The cells were injected intraperitoneally into 1- to 2-day-old scurfy neonates. Mice were monitored for external signs of disease and were killed after 25--60 days for analysis.

NanoString Gene Expression Analysis {#S27}
-----------------------------------

Purified RNA was hybridized with a custom-made CodeSet provided by NanoString Technologies. Bar codes were counted (1,150 fields of view per sample) on an nCounter Digital Analyzer. Data were processed using nSolver Analysis Software by normalization to the geometric mean of the positive control spike count in addition to the 4 reference genes (Actv, Gapdh, Hprt, and Tubb5).

Statistical Analysis {#S28}
--------------------

Statistical analysis was performed using Prism software (GraphPad, La Jolla, CA, USA). p values \<0.05 were considered significant.
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![SGK1 Signaling Is Active in Treg Cells and Inhibits Treg Cell Frequency\
(A) *In-vitro*-differentiated Th0, Th1, Th2, Th17, and pTreg cells and tTreg cells were harvested for qPCR. mRNA levels of *Sgk1* genes for different subsets are shown.\
(B) The expression of indicated molecules on naive T cells and tTreg cells was determined by flow cytometry.\
(C) Quantification of the mean fluorescence intensity (MFI) of the molecules indicated in (B).\
(D) Comparison of phosphorylation of p27 and Foxo1 between freshly isolated and pre-activated (anit-CD3/28) Treg cells by flow cytometry.\
(E) Quantification of the MFI of the molecules indicated in (D).\
(F) The percentage of Foxp3^+^ Treg cells in spleen, drain lymphoid nodes (dLN), mesenteric LN (mLN), lamina propria (LP), liver, and lung from WT and *Foxp3^Cre^Sgk1^fl/fl^* mice was determined by flow cytometry.\
(G) Quantification of the frequency of Foxp3^+^ Npr1^+^ in CD4^+^ tTreg cells within indicated mice as in (G).\
(H) Comparison of Ki67 between activated (anit-CD3/28) tTreg cells from spleen and LNs of WT and *Foxp3^Cre^Sgk1^fl/fl^* mice.\
Data are pooled from three independent experiments (A, C, and E) or representative of three independent experiments (B, D, and F--H) with n R 4 mice each group. Error bars represent SEM. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 (Student's t test, error bars, SD). See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms937387f1){#F1}

![SGK1 Limits tTreg Cell function\
(A) Proliferation of WT naive CD4^+^ T cells in the presence of anti-CD3 and irritated antigen presentation cells (APCs) and tTreg cells from WT and *Foxp3^Cre^Sgk1^fl/fl^* mice. Data shown are presented as mean \[^3^H\]-thymidine incorporation.\
(B) The expression of indicated molecules on tTreg cells from WT and *Foxp3^Cre^Sgk1^fl/fl^* mice was determined by flow cytometry.\
(C) Disease score of EAE development in *Foxp3^Cre^Sgk1^+/+^* and *Foxp3^Cre^Sgk1^fl/fl^* mice by MOG immunization.\
(D) IL-17 and IFN-γ secretion and Foxp3 expression by CD4^+^ T cells within the CNS was determined by flow cytometry.\
(E) Quantification of the frequency of IFN-γ^+^, IL-17^+^, and Foxp3^+^ in CD4^+^ cells within indicated mice CNS as in Figure 2D.\
(F) BrdU incorporation in proliferating CTLA-4^+^ and ICOS^+^ Treg cells in the CNS of indicated mice was determined by flow cytometry.\
Data are pooled from three independent experiments (A) or representative of three independent experiments (B--F) with n ≥ 4 mice each group. Error bars represent SEM. \*p \< 0.05, \*\*p \< 0.01 (Student's t test, error bars, SD).](nihms937387f2){#F2}

![SGK1 Represses Treg Cell Homeostasis\
(A and B) Flow cytometry (A) and quantitative analysis (B) of CD44 and CD62L expression on CD4^+^ T cells from spleen and draining lymph nodes (dLNs) of WT and *Foxp3^Cre^Sgk1^fl/fl^* mice at 30 weeks of age.\
(C and D) Flow cytometry (C) and quantitative analysis (D) of the IFN-γ expression in isolated CD4^+^CD44^hi^ cells from WT and *Foxp3^Cre^Sgk1^fl/fl^* mice at 30 weeks of age.\
(E and F) Flow cytometry (E) and quantitative analysis (F) of Foxp3 expression by cells isolated from the spleens and dLNs of scurfy recipients of WT or *Foxp3^Cre^Sgk1^fl/fl^* Treg cells.\
(G and H) Flow cytometry (G) and quantitative analysis (H) of Foxp3 expression by cells isolated from the spleens and dLNs of scurfy recipients of WT or *Foxp3^Cre^Sgk1^fl/fl^* Treg cells.\
Data are representative of three independent experiments (A--F) with n ≥ 4 mice each group. Error bars represent SEM. \*p \< 0.05, \*\*p \< 0.01 (Student's t test, error bars, SD).](nihms937387f3){#F3}

![IL-23R and SGK1 Form Positive Signaling Feedback Loop\
(A) T cell-induced colitis was performed on *Rag2*^−^*^/^*^−^ mice by using *Il23r^gfp^* donor CD4^+^CD25^−^CD45RB^hi^ GFP^−^ T cells. 6 weeks after transfer, qPCR analysis of the indicated genes in CD4^+^GFP^+^ or CD4^+^GFP^−^ cells sorted from the colon *Rag2*^−^*^/^*^−^ mice.\
(B) qPCR of *Sgk1* mRNA expression in naive CD4^+^ T cells transduced with retrovirus expressing control vector (Ctrl RV) or IL-23R and treated with indicated cytokines; on day 3, RNA was isolated from GFP^+^ cells for analysis.\
(C and D) qPCR of (C) *Il23r* or (D) *Foxp3* mRNA expression in naive CD4^+^ T cells transduced with retrovirus expressing control vector (Ctrl RV) or SGK1 and treated with indicated cytokines; on day 3, RNA was isolated from GFP^+^ cells for analysis.\
(E) Naive CD4^+^ T cells from *Cd4^Cre^Sgk1^fl/fl^* and WT mice were differentiated into Th17 cells with TGF-β and IL-6 (left) or restimulated with IL-23 (right). IL-17 and Foxp3 expression were assessed by flow cytometry.\
(F) Schematic illustration of adoptive transfer experiments shown in (G).\
(G) CD45.2^+^CD4^+^CD45RB^hi^CD25^−^ cells were transferred into *Rag2*^−^*^/^*^−^ mice from WT, *Il23r*^−^*^/^*^−^, *Sgk1*^−^*^/^*^−^, or *Il23r*^−^*^/^*^−^*Sgk1*^−^*^/^*^−^ donor mice, together with congenic CD45.1^+^CD4^+^CD45RB^hi^CD25^−^ cells as internal control at a ratio of 1:1. 10 weeks after transfer, IFN-γ and IL-17 production from CD4^+^ T cells within the LP were examined by flow cytometry.\
(H) Foxp3 expression from CD4^+^ T cells in the samples as shown in (G) was examined by flow cytometry.\
(I) Quantification of the frequency of IFN-γ, IL-17, or Foxp3 among CD4^+^ T cells from CD45.2^+^ donor mice in the LP.\
Data are pooled from three independent experiments (A--D) or representative of three independent experiments (E--I) with n ≥ 4 mice each group. Error bars represent SEM. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 (Student's t test, error bars, SD). See also [Figures S2 and S3](#SD1){ref-type="supplementary-material"}.](nihms937387f4){#F4}

![SGK1 Regulates IL-23R Expression and Reciprocal Differentiation of Th17 and Treg Cells during Intestinal Inflammation\
(A) Body weight of *Rag2*^−^*^/^*^−^ mice transferred with CD4^+^CD25^−^CD45RB^hi^ T cells from WT or *Cd4^Cre^Sgk1^fl/fl^* mice.\
(B) H&E staining of colon samples from the different groups as in (A) (original magnification, ×20).\
(C and D) Flow cytometry (C) and quantitative analysis (D) of IL-23R expression from CD4^+^ T cells isolated from mLN and LP from indicated groups as in (A) 10 weeks after colitis induction.\
(E and F) Flow cytometry (E) and quantitative analysis (F) of IL-17 and IFN-γ, Foxp3 expression by CD4^+^ T cells isolated from LP from indicated groups as in (A) 10 weeks after colitis induction. Data are representative of three independent experiments. Error bars represent SEM. \*p \< 0.05, \*\*p \< 0.01 (Student's t test, error bars, SD).](nihms937387f5){#F5}

![SGK1 Reduces pTreg Differentiation and Function\
(A) Naive CD4^+^ T cells from WT and *Foxp3^Cre^ Sgk1^fl/fl^* mice were differentiated into Treg cells with indicated dose of TGF-β. Foxp3 expression was assessed by flow cytometry.\
(B) Proliferation of WT naive CD4^+^ T cells in the presence of anti-CD3 and irritated APCs and GFP^+^ (Foxp3^+^) pTreg cells from *Foxp3^Cre^Sgk1^+/+^* and *Foxp3^Cre^Sgk1^fl/fl^* mice.\
(C) Body weight of *Rag2*^−^*^/^*^−^ mice after transferred i.p. with CD4^+^CD25^−^CD45RB^hi^Foxp3^−^ T cells from WT or *Foxp3^Cre^Sgk1^fl/fl^* mice.\
(D) H&E staining of colon samples from the different groups as in (C) (original magnification, 320).\
(E and F) Flow cytometry (E) and quantitative analysis (F) of IL-17, IFN-γ, and Foxp3 expression by CD4^+^ T cells isolated from LP from indicated groups as in (C) 10 weeks after colitis induction. Data are representative of three independent experiments with n ≥ 4 mice each group. Error bars represent SEM. \*p \< 0.05, \*\*p \< 0.01 (Student's t test, error bars, SD).](nihms937387f6){#F6}

![SGK1 Deficiency Results in Compromised Foxo1 Nuclear Exclusion, Promoting Foxp3 Expression\
(A) Volcano plot comparing the p value versus fold change for probes of nanostring data from *Foxp3^Cre^Sgk1^fl/fl^* versus WT tTreg cells. The key genes of Treg and Th17 cells are highlighted in red and blue, respectively (transcripts upregulated in Treg cells) and green (transcripts downregulated in Th17 cells).\
(B) qPCR validation of signature genes in (A) from WT and *Foxp3^Cre^Sgk1^fl/fl^* tTreg cells.\
(C) Representative immunostaining images of Foxp3, Foxo1, and SGK1. CD4^+^Foxp3^+^ tTreg cells isolated from WT or *Foxp3^Cre^Sgk1^fl/fl^* mice were left untreated or stimulated with anti-CD3/CD28 on chamber slides at 37° C for 20 min.\
(D) Quantitative analysis of Foxo1 localization in Treg cells between WT or *Foxp3^Cre^Sgk1^fl/fl^* mice. Cyto, Foxo1 localized in the cytosol; Cyto/Nuc, Foxo1 localized in both the cytosol and the nucleus; Nuc, Foxo1 localized in the nucleus.\
(E) WT or *Foxp3^Cre^Sgk1^fl/fl^* CD4^+^ naive T cells were transfected with a luciferase reporter containing Foxp3 CNS1 region construct with or without Foxo1 binding site mutation and stimulated with Th0 or pTreg conditions. Luciferase activity was measured 24 hr later.\
(F--H) Naive CD4^+^ T cells were transduced with retrovirus expressing control vector (Ctrl), WT SGK1, the constitutively active (^S422D^SGK1) or the inactive forms of SGK1 (^K127N^SGK1) under pTreg conditions. (F) Foxp3 expression in transfected cells was determined by flow cytometry. (G) Foxo1 localization within indicated groups was examined. Arrows indicate nuclear Foxo1. DAPI (blue), Foxo1 (red). Scale, 500 μm. (H) Foxo1 mRNA expression within different groups was determined by qPCR.\
Data are representative of three independent experiments (A, C, D, F, and G) or pooled from three independent experiments (B, E, and H) with n ≥ 4 mice each group. Error bars represent SEM. \*p \< 0.05, \*\*p \< 0.01 (Student's t test, error bars, SD).](nihms937387f7){#F7}

###### Highlights

-   SGK1 restrains Treg cell expansion and function

-   SGK1 represses *Foxp3* expression via regulating IL-23R

-   SGK1 reciprocally regulates development of Th17/Treg balance

-   SGK1 restrains Foxp3 expression via reduced Foxo1 nuclear exclusion
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